This presentation provides detailed information on trial design criteria, screening processes, confirmation of eligibility, randomisation procedures, and screening & enrolment logging in the context of devastating brain injury treatments. It covers inclusion and exclusion criteria, PI responsibiliti

5 views • 15 slides

Dive into the world of critical appraisal in medicine, covering topics such as format, statistics, types of data, p-values, confidence intervals, randomisation, blinding, and more. Learn how to dissect research papers, interpret results, and apply findings to clinical practice effectively.

4 views • 68 slides

This Phase 2 clinical trial compares the efficacy of NGM282 (3 mg vs 6 mg) versus placebo in patients with NASH. The primary endpoint is a 5% reduction in liver fat content at 12 weeks. Randomisation was stratified by diabetes status, and stable Type 2 diabetes and lipid-lowering treatments were mai

0 views • 6 slides